✦ LIBER ✦
A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings
✍ Scribed by KANE, G; POLLICE, M; KIM, C; COHN, J; DWORSKI, R; MURRAY, J; SHELLER, J; FISH, J; PETERS, S
- Book ID
- 119495223
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 928 KB
- Volume
- 97
- Category
- Article
- ISSN
- 1097-6825
No coin nor oath required. For personal study only.